PremiumThe FlyViatris appoints Hemanth Varghese as chief strategy officer Viatris reaches nationwide settlement to resolve opioid-related claims Levi & Korsinsky LLP Notifies Shareholders of Viatris Inc.(VTRS) of a Class Action Lawsuit and an Upcoming Deadline PremiumThe FlyViatris price target lowered to $10 from $11 at BofA Viatris price target lowered to $9 from $12 at Barclays Viatris Reports Strong 2024 Financial Results PremiumThe FlyViatris doesn’t see FDA warning impacting current 2024 financial guidance Viatris confirms receipt of warning letter, import alert for India facility Viatris announces publication of CARE study results 
